等待开盘 04-02 09:30:00 美东时间
+0.140
+2.11%
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
RBC Capital analyst Michael Carroll maintains Diversified Healthcare (NASDAQ:DHC) with a Sector Perform and raises the price target from $5 to $6.
03-03 00:18
DHC FY2025 net loss narrows 22.8% to USD 285.9 million Diversified Healthcare Trust (DHC) reported FY 2025 total revenues of USD 1.54 billion and a FY 2025 net loss of USD 285.9 million. FY 2025 property net operating income (NOI) was USD 278.5 million, including SHOP NOI of USD 139.3 million (+31.3
02-24 19:02
Diversified Healthcare (NASDAQ:DHC) reported its Q4 earnings results on Monday,...
02-24 05:20
Diversified Healthcare (NASDAQ:DHC) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 350 percent increase over earnings of $0.02 per share from the same period last year.
02-24 05:18
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
Diversified Healthcare (NASDAQ:DHC) is preparing to release its quarterly earni...
02-21 01:01
Diversified Healthcare Trust Schedules Conference Call to Discuss Financial Results Diversified Healthcare Trust will release its fourth quarter 2025 financial results after the Nasdaq closes on Monday, February 23, 2026. A conference call to discuss these results will be held on Tuesday, February 2
01-28 01:21
Diversified Healthcare Trust (DHC) declared $0.01/share quarterly dividend, in line with previous. Forward yield 0.75% Payable Feb. 19; for shareholders of record Jan. 26; ex-div Jan. 26. See DHC Divi...
01-15 21:27